Persist AI

About

Persist AI is a biotechnology company based in West Sacramento, California, founded in 2022. The company focuses on AI-driven robotics to enhance pharmaceutical drug formulation development, particularly for long-acting injectables and complex delivery systems. By integrating predictive AI models, custom robotics, and high-throughput experimentation, Persist AI significantly reduces formulation timelines and costs compared to traditional methods. The company operates on a fee-for-service model, allowing clients to retain all intellectual property and commercialization rights. Persist AI's core offerings include its Cloud Lab platform for remote high-throughput screening and formulation analysis, formulation development support, an AI platform for formulation prediction, and commercial cGMP manufacturing. The robotic lab facilitates parallel testing of various formulations, supporting a range of modalities. Persist AI collaborates with partners like Nivagen Pharmaceuticals and Microsoft, and is backed by Y Combinator. The leadership team includes CEO Karthik Raman and COO Christopher Shelner, both with extensive experience in automation and formulation.